Spending power
TheGrid Corporate Spending Power index would rate purchasing capacity from registry, scale and activity signals.
Spending power
Key facts
Counted staff
1
self-reported band not used
Founded
2019
7 years
Legal entities
None matched
Office countries
1
1 address
Funding rounds
None on record
Company type
Privately Held
self-reported
Description
Cholrem is a specialty biopharmaceutical company leveraging advanced proprietary technologies to develop first-in-class treatments.
Research into cyclodextrin has quickly proven to emerge as a major therapeutically beneficial product for the 2020 decade.
Scientific studies and research into cyclodextrin are showing that enhanced cholesterol transport within the body has major benefits in a huge range of health issues, including Atherosclerosis, Alzheimer's disease, Macular degeneration, and so on.
More and more companies are beginning to research end products for cyclodextrin but are years away from having approved products ready for market.
Some of these companies are solely dedicated to cyclodextrin research and are valued in excess of $100 million without a single commercial product.
While these companies struggle to develop a product for a dedicated treatment, Cholrem has developed its own cyclodextrin (CAVADEX®) and has moved forward and made CAVADEX® available for general use through RemChol®.
Cholrem Inc. products provide immediate access to CAVADEX® by the consumer, and as the science shows, CAVADEX® not only avoids harm but also contributes positively to your overall health with each dose you take.
Cholrem Inc. is the only company with a commercially available cyclodextrin treatment. Our first product, the RemChol enema, is now available giving consumers immediate access to this incredible compound.
The Cholrem Inc. products are designed to deliver up to 8 grams of CAVADEX® daily. This accumulates to over 2,400 grams annually, providing huge health benefits to the consumer.
As the science continues to show the benefits of cyclodextrin, Cholrem Inc. is ready to satisfy the increasing demand for this new health-improving treatment.
Locations
Country footprint
Show as table · Offices in 1 country
| Countries | 1 |
|---|---|
| Primary country | AU |
All codes: AU
Addresses
- AUGold Coast, QueenslandPrimary
Grid intelligence Members
Signals & hiring
Hiring, headcount and registry-change signals, streamed to members.
Latest signal
Hiring activity
Headcount trend
Financials
Registry-filed capital and financial indicators, standardised by TheGrid.
Paid-up capital
Fiscal period
Registered charges
Revenue
Profit / loss
FAQ
How many people work at CHOLREM?
1 counted staff profiles at January 2026. The brand's self-reported band sits above that count and is not published as a headcount.
Where does CHOLREM have offices?
One address on record, Australia only. Primary: Gold Coast, Queensland.
Has CHOLREM raised funding?
None linked to this brand.
Which companies are listed alongside CHOLREM?
1 profile lists CHOLREM as a peer — 86th percentile in Medical Practices. It lists two peers of its own. AtheroCare lists it back.